Home Amylon Therapeutics

Amylon Therapeutics

In operation
Seed Round Financing
A Biotechnology Company
Basic
Enterprise Profile

Basic Information

Amylon Therapeutics is a biotechnology company targeting CNS diseases through supergenetic approaches, focusing on rare genetic disorders that may serve as potential pathways for more frequently occurring conditions.
Amylon Therapeutics
SouthHolland,Netherlands
unclear
January 01, 2017
--
info@amylontx.com

Enterprise Profile

Technology
Technology Gene Technology Genetic Testing
Concept
Treatment of Diseases Rare Diseases